Dr. Abhishek Shukla explained today that tuberculosis treatment involves multiple medicines because the TB bacteria are slow-growing and can easily develop resistance if only one drug is used. To prevent this, treatment is given as a combination therapy, usually including isoniazid, rifampicin, pyrazinamide, and ethambutol in the initial phase. Each medicine targets the bacteria in a different way, ensuring maximum killing of the germs and reducing the risk of drug-resistant TB. He further discu